Back to Search
Start Over
RVX-208 THE FIRST SELECTIVE BROMODOMAIN EXTRA-TERMINAL PROTEIN INHIBITOR BEING DEVELOPED FOR PATIENTS WITH HIGH RESIDUAL RISKS OF CARDIOVASCULAR DISEASE
- Source :
- Journal of the American College of Cardiology. 65:A258
- Publication Year :
- 2015
- Publisher :
- Elsevier BV, 2015.
Details
- ISSN :
- 07351097
- Volume :
- 65
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi.dedup.....bfe8719d0ce64ecb4a0754fd84e47176